Clinical Trial Update: German PMS Trial (AWB) to Evaluate Therapy in Reflux Disease and NSAR-Symptoms

View source ↗

Summary

A German post-marketing surveillance trial evaluating a therapy for reflux disease and NSAID-related symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux | Status: COMPLETED